Qiagen Registers QIAsymphony Sample Prep Module with Chinese SFDA | GenomeWeb

Qiagen said today that it has registered its QIAsymphony SP instrument with China's State Food and Drug Administration.

The QIAsymphony SP fully automates assay sample preparation, and can handle an extensive variety of starting materials such as blood and tissue samples, with a wide range of input and output volumes and formats, Qiagen said.

The company added that more than 40 protocols to isolate, purify, and prepare DNA, RNA, and proteins have been optimized for use on the SP instrument.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.